BCOP Exam Questions with Correct Answers| Latest Update

BCOP Exam Questions with Correct
Answers| Latest Update

Section 1: Ocular Pharmacology & Pharmacokinetics (Questions 1-10)
jh jh jh jh jh jh jh




1. The volume of the average adult tear film is approximately:
jh jh jh jh jh jh jh jh jh jh




A) 1–2 µL
jh jh




B) 7–10 µL
jh jh




C) 20–25 µL
jh jh




D) 50–100 µL
jh jh




2. A drug with high lipophilicity will most likely:
jh jh jh jh jh jh jh jh




A) Have poor corneal penetration
jh jh jh jh




B) Be poorly absorbed systemically
jh jh jh jh




C) Have a longer duration of action due to binding to melanin
jh jh jh jh jh jh jh jh jh jh jh




D) Exhibit first-pass metabolism in the liver
jh jh jh jh jh jh




3. The primary route of drug elimination from the anterior chamber is via:
jh jh jh jh jh jh jh jh jh jh jh jh




A) The uveoscleral pathway
jh jh jh




B) The trabecular meshwork and Schlemm’s canal
jh jh jh jh jh jh




C) The nasolacrimal duct
jh jh jh




D) Aqueous humor turnover through the angle
jh jh jh jh jh jh




4. Which of the following is a prodrug that is hydrolyzed to its active form by corneal ester
jh jh jh jh jh jh jh jh jh jh jh jh jh jh jh jh jh




ases?
A) Latanoprost
jh




B) Timolol
jh




C) Prednisolone acetate
jh jh




D) Pilocarpine
jh




5. The primary mechanism of drug absorption through the conjunctiva is:
jh jh jh jh jh jh jh jh jh jh




A) Transcellular passive diffusion
jh jh jh




B) Paracellular transport through tight junctions
jh jh jh jh jh




C) Active transport via carrier proteins
jh jh jh jh jh




D) Pinocytosis
jh




6. Which factor most significantly reduces the bioavailability of topically applied ophthalmi
jh jh jh jh jh jh jh jh jh jh jh




c drugs?
jh




A) Tear film turnover
jh jh jh




B) Corneal metabolism
jh jh

,C) Lacrimal drainage and nasolacrimal reflex
jh jh jh jh jh




D) Binding to tear proteins
jh jh jh jh




7. The pH of a topical ophthalmic solution ideally should be:
jh jh jh jh jh jh jh jh jh jh




A) 3.0–4.0 to enhance preservative efficacy
jh jh jh jh jh




B) 5.0–6.0 to match the tear film buffer capacity
jh jh jh jh jh jh jh jh




C) 7.0–8.0 to maximize non-ionized drug fraction
jh jh jh jh jh jh




D) 4.5–8.5, but ideally close to 7.4 to avoid stinging
jh jh jh jh jh jh jh jh jh




8. The enzyme responsible for the metabolism of topical glucocorticoids in the cornea is:
jh jh jh jh jh jh jh jh jh jh jh jh jh




A) Cytochrome P450
jh jh




B) Acetylcholinesterase
jh




C) 11-beta-hydroxysteroid dehydrogenase
jh jh




D) Monoamine oxidase
jh jh




9. Following topical instillation, the peak concentration of a drug in the aqueous humor ge
jh jh jh jh jh jh jh jh jh jh jh jh jh jh




nerally occurs within:
jh jh




A) 5–10 minutes
jh jh




B) 30–60 minutes
jh jh




C) 2–4 hours
jh jh




D) 6–8 hours
jh jh




10. The primary barrier to drug penetration in the cornea is the:
jh jh jh jh jh jh jh jh jh jh jh




A) Epithelium
jh




B) Bowman’s layer
jh jh




C) Stroma
jh




D) Endothelium
jh




Answer Key (1-10): jh jh




1. B

2. C

3. D

4. A

5. B

6. C

7. D

8. C

, 9. B

10. A



Section 2: Autonomic Nervous System & Glaucoma (Questions 11-20)
jh jh jh jh jh jh jh jh




11. Which of the following beta-
jh jh jh jh jh




blockers has the greatest intrinsic sympathomimetic activity (ISA)?
jh jh jh jh jh jh jh




A) Timolol
jh




B) Betaxolol
jh




C) Carteolol
jh




D) Levobunolol
jh




12. The mechanism of action of brimonidine is:
jh jh jh jh jh jh jh




A) Alpha-2 adrenergic agonist
jh jh jh




B) Alpha-1 adrenergic agonist
jh jh jh




C) Beta-1 adrenergic antagonist
jh jh jh




D) Carbonic anhydrase inhibitor
jh jh jh




13. Which prostaglandin analogue is a prodrug that requires corneal hydrolysis to become
jh jh jh jh jh jh jh jh jh jh jh jh jh




active?
A) Travoprost
jh




B) Latanoprost
jh




C) Bimatoprost
jh




D) Tafluprost
jh




14. The primary site of action of pilocarpine is the:
jh jh jh jh jh jh jh jh jh




A) Ciliary muscle
jh jh




B) Trabecular meshwork
jh jh




C) Schlemm’s canal
jh jh




D) Choroid
jh




15. Which of the following is a contraindication for the use of topical beta-blockers?
jh jh jh jh jh jh jh jh jh jh jh jh jh




A) Hypertension
jh




B) Migraine headaches
jh jh




C) Reactive airway disease (asthma)
jh jh jh jh




D) Hyperthyroidism
jh




16. The most common ocular side effect of prostaglandin analogues is:
jh jh jh jh jh jh jh jh jh jh




A) Corneal verticillata
jh jh




B) Cystoid macular edema
jh jh jh




C) Iris hyperpigmentation and eyelash growth
jh jh jh jh jh




D) Conjunctival hyperemia
jh jh

, 17. Dorzolamide is a:
jh jh jh




A) Beta-blocker
jh




B) Alpha-agonist
jh




C) Carbonic anhydrase inhibitor
jh jh jh




D) Rho kinase inhibitor
jh jh jh




18. Netarsudil (Rhopressa) inhibits which enzyme?
jh jh jh jh jh




A) Carbonic anhydrase
jh jh




B) Rho-associated protein kinase (ROCK)
jh jh jh jh




C) Acetylcholinesterase
jh




D) Prostaglandin synthase
jh jh




19. The peak ocular hypotensive effect of latanoprost occurs approximately:
jh jh jh jh jh jh jh jh jh




A) 2 hours after instillation
jh jh jh jh




B) 8–12 hours after instillation
jh jh jh jh




C) 24 hours after instillation
jh jh jh jh




D) 48 hours after instillation
jh jh jh jh




20. A patient using a combination of dorzolamide and timolol (Cosopt) should be monitore
jh jh jh jh jh jh jh jh jh jh jh jh jh




d for:
jh




A) Hypokalemia
jh




B) Hypercalcemia
jh




C) Metabolic acidosis
jh jh




D) Respiratory depression
jh jh




Answer Key (11-20): jh jh




11. C

12. A

13. A

14. A

15. C

16. D

17. C

18. B

19. B

20. C